Prevention of Oral Mucositis Using Photobiomodulation Therapy

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 4, 2020

Primary Completion Date

May 30, 2021

Study Completion Date

May 30, 2021

Conditions
Oral Mucositis
Interventions
DEVICE

Photobiomodulation Therapy (PBM)

The PBM will be delivered through application of the LED Cluster Probe externally to the right external buccal, left external buccal, mid face with mouth open and submandibular and left/right cervical. Patients who develop an oral lesion, intra-oral directed therapy will be administered with the dental light probe. For patients that can tolerate, an intraoral probe will deliver light directly onto the oral mucosa, this will then replace the mid face application with mouth open. Each laser application will be timed at 60 seconds.

OTHER

Pain and Oral Function Assessment

After the 6-minute laser/ treatment session the child and parent will complete the mucositis evaluation scale on paper or ipad which includes self-report oral function specific to ability to swallow, eat and drink, as well as the patient's self-reported need for medication specific to mouth pain.

OTHER

Parent-Reported Satisfaction Survey

A parent-reported satisfaction survey will be administered via paper questionnaire after the initial LLLT treatment. Parent satisfaction will be reported by parents on a 5-point Likert scale to questions adapted from a parent satisfaction survey used in a study regarding child life services in pediatric imaging.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

Association of Pediatric Hematology Oncology Nurses

OTHER

lead

St. Jude Children's Research Hospital

OTHER

NCT04227340 - Prevention of Oral Mucositis Using Photobiomodulation Therapy | Biotech Hunter | Biotech Hunter